Literature DB >> 2271856

Hypoalbuminaemia after prolonged treatment with recombinant granulocyte macrophage colony stimulating factor.

R S Kaczmarski1, G J Mufti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2271856      PMCID： PMC1664465          DOI： 10.1136/bmj.301.6764.1312-a

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Recombinant human granulocyte/macrophage colony-stimulating factor enhances monocyte cytotoxicity and secretion of tumor necrosis factor alpha and interferon in cancer patients.

Authors:  E J Wing; D M Magee; T L Whiteside; S S Kaplan; R K Shadduck
Journal:  Blood       Date:  1989-02-15       Impact factor: 22.113

2.  Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression.

Authors:  K S Antman; J D Griffin; A Elias; M A Socinski; L Ryan; S A Cannistra; D Oette; M Whitley; E Frei; L E Schnipper
Journal:  N Engl J Med       Date:  1988-09-08       Impact factor: 91.245

3.  Production of interleukin-1 alpha, interleukin-1 beta and tumor necrosis factor by human mononuclear cells stimulated with granulocyte-macrophage colony-stimulating factor.

Authors:  S D Sisson; C A Dinarello
Journal:  Blood       Date:  1988-10       Impact factor: 22.113

4.  Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation.

Authors:  S J Brandt; W P Peters; S K Atwater; J Kurtzberg; M J Borowitz; R B Jones; E J Shpall; R C Bast; C J Gilbert; D H Oette
Journal:  N Engl J Med       Date:  1988-04-07       Impact factor: 91.245

5.  Transgenic mice expressing a hemopoietic growth factor gene (GM-CSF) develop accumulations of macrophages, blindness, and a fatal syndrome of tissue damage.

Authors:  R A Lang; D Metcalf; R A Cuthbertson; I Lyons; E Stanley; A Kelso; G Kannourakis; D J Williamson; G K Klintworth; T J Gonda
Journal:  Cell       Date:  1987-11-20       Impact factor: 41.582
  5 in total
  2 in total

1.  Treatment of neutropenia in Felty's syndrome with granulocyte-macrophage colony-stimulating factor--hematological response accompanied by pulmonary complications with lethal outcome.

Authors:  A R Gari-Bai; C Rochlitz; M Riewald; J Oertel; D Huhn
Journal:  Ann Hematol       Date:  1992-11       Impact factor: 3.673

Review 2.  Clinical toxicity of cytokines used as haemopoietic growth factors.

Authors:  T Vial; J Descotes
Journal:  Drug Saf       Date:  1995-12       Impact factor: 5.606
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.